About the Ovarian Cancer Session
Ovarian cancer research has made significant strides in recent years, focusing on early detection, genetic factors, and novel treatments. Researchers are developing advanced diagnostic tools, such as liquid biopsies, to detect cancer markers in blood, aiming for earlier and more accurate diagnoses. Genetic studies have identified key mutations, particularly in the BRCA1 and BRCA2 genes, that increase susceptibility, leading to improved screening for at-risk populations. Additionally, immunotherapy and targeted therapies, such as PARP inhibitors, are showing promise in clinical trials, offering more personalized and effective treatment options. Continued research is vital for improving survival rates and quality of life for ovarian cancer patients.
Topics Covered in Ovarian Cancer
High-Grade Serous Carcinoma
BRCA Mutations
Early Detection
Cytoreductive Surgery
PARP Inhibitors
Platinum Resistance
Related Scientific Sessions at CIOC 2027
Why Attend the Ovarian Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ovarian Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ovarian Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ovarian Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ovarian Cancer Conference 2027 — FAQs
What is the Ovarian Cancer track at CIOC 2027?
The Ovarian Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ovarian Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ovarian Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Ovarian Cancer are all welcome — whether presenting or attending.
Can I present my research in the Ovarian Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ovarian Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ovarian Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.